+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiovascular Surgery Devices Market by Product Type, Procedure Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010724
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiovascular Surgery Devices Market grew from USD 1.57 billion in 2023 to USD 1.65 billion in 2024. It is expected to continue growing at a CAGR of 5.43%, reaching USD 2.27 billion by 2030.

The Cardiovascular Surgery Devices market encompasses a wide array of tools and instruments utilized in procedures aimed at treating cardiovascular diseases. These devices range from minimally invasive instruments to advanced surgical tools employed during complex heart surgeries. The necessity for such devices is underscored by the rising incidence of heart-related ailments globally, fueled by factors like aging populations and lifestyle-related disorders. Applications of these devices span coronary artery bypass grafting, heart valve repair or replacement, and transcatheter interventions, with end-users primarily being hospitals and specialized cardiac care centers.

Significant growth factors influencing this market include technological advancements leading to enhanced precision and safety of surgical procedures, increased patient preference for minimally invasive surgeries, and the surge in healthcare expenditure. Moreover, the continuous rise in cardiovascular disease prevalence creates substantial demand and opportunity for market expansion. Emerging economies represent untapped markets, presenting opportunities through improved healthcare infrastructure and increased adoption of advanced cardiovascular procedures. Companies could capitalize on these opportunities by investing in R&D for innovative device development and market penetration strategies in these regions.

Conversely, limitations such as stringent regulatory hurdles, high costs of advanced devices, and reimbursement challenges pose significant barriers to market growth. Furthermore, a shortage of skilled professionals to operate complex surgical devices can inhibit growth potential. As an avenue for innovation, focusing on the development of AI and machine learning-powered devices for real-time data analysis during surgeries could propel advancements significantly.

The nature of the market is dynamic, characterized by rapid technological changes and a competitive landscape with numerous players striving for innovation. Future growth will likely hinge on balancing cost-effective solutions with cutting-edge technology, expanding geographic reach, and enhancing device usability. By concentrating on these aspects, businesses could better navigate the challenges and leverage the manifold opportunities within the cardiovascular surgery devices market.

Understanding Market Dynamics in the Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
    • Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
    • Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
    • Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
  • Market Restraints
    • High Cost for advance procedure and material in cardiovascular surgery
  • Market Opportunities
    • Integration of artificial intelligence and machine learning in surgical device
    • Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
  • Market Challenges
    • Increased competition from alternative treatments and non-invasive cardiovascular procedures.

Exploring Porter’s Five Forces for the Cardiovascular Surgery Devices Market

Porter’s Five Forces framework further strengthens the insights of the Cardiovascular Surgery Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cardiovascular Surgery Devices Market

External macro-environmental factors deeply influence the performance of the Cardiovascular Surgery Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, GE HealthCare Technologies Inc., Getinge AB, Johnson & Johnson, LivaNova PLC, Maquet Cardiovascular LLC, Medtronic plc, MicroPort Scientific Corporation, Philips Healthcare, Siemens Healthineers AG, St. Jude Medical, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Cardiopulmonary Bypass Equipment
      • Cannulae
      • Oxygenators
      • Reservoirs
    • Heart Valve Devices
      • Mechanical Heart Valves
      • Tissue Heart Valves
      • Transcatheter Heart Valves
    • Perfusion Disposables
      • Blood Cardioplegia
  • Procedure Type
    • Cardiovascular Surgery
    • Coronary Artery Bypass Grafting (CABG)
  • End User
    • Cardiac Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
5.1.1.2. Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
5.1.1.3. Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
5.1.1.4. Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
5.1.2. Restraints
5.1.2.1. High Cost for advance procedure and material in cardiovascular surgery
5.1.3. Opportunities
5.1.3.1. Integration of artificial intelligence and machine learning in surgical device
5.1.3.2. Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
5.1.4. Challenges
5.1.4.1. Increased competition from alternative treatments and non-invasive cardiovascular procedures.
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cardiovascular Surgery Devices Market, by Product Type
6.1. Introduction
6.2. Cardiopulmonary Bypass Equipment
6.2.1. Cannulae
6.2.2. Oxygenators
6.2.3. Reservoirs
6.3. Heart Valve Devices
6.3.1. Mechanical Heart Valves
6.3.2. Tissue Heart Valves
6.3.3. Transcatheter Heart Valves
6.4. Perfusion Disposables
6.4.1. Blood Cardioplegia
7. Cardiovascular Surgery Devices Market, by Procedure Type
7.1. Introduction
7.2. Cardiovascular Surgery
7.3. Coronary Artery Bypass Grafting (CABG)
8. Cardiovascular Surgery Devices Market, by End User
8.1. Introduction
8.2. Cardiac Centers
8.3. Hospitals
9. Americas Cardiovascular Surgery Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cardiovascular Surgery Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cardiovascular Surgery Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CARDIOVASCULAR SURGERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CARDIOVASCULAR SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARDIOVASCULAR SURGERY DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY BLOOD CARDIOPLEGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 48. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 49. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 50. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 80. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 81. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 82. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 83. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 86. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 87. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 88. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 89. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 100. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 135. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 136. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 154. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 155. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 189. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 190. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 191. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 208. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 209. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 213. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 214. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 215. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 219. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 220. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 221. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 245. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 278. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cardiovascular Surgery Devices market, which are profiled in this report, include:
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Johnson & Johnson
  • LivaNova PLC
  • Maquet Cardiovascular LLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Philips Healthcare
  • Siemens Healthineers AG
  • St. Jude Medical, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information